期刊文献+

不同用药方案治疗社区获得性肺炎的疗效及经济学分析 被引量:1

不同用药方案治疗社区获得性肺炎的疗效及经济学分析
下载PDF
导出
摘要 目的探讨两种用药方案治疗社区获得性肺炎(CAP)的疗效及经济效果。方法将2009年12月~2010年6月收治的50例CAP患者分为两组,分别采用头孢唑林和阿奇霉素治疗,比较两组的治疗效果并进行药物经济学成本-效果分析。结果头孢唑林组的总有效率为84.0%,阿奇霉素的总有效率为92.0%,两组之间无显著性差异,P>0.05。两种用药方案的成本分别为1016.85元、1057.45元。成本效果比为12.11、11.49,有显著性差异,P<0.05。结论阿奇霉素治疗CAP的方案优于头孢唑林。 Objective Discusses two kinds of treatment regimen community-acquired pneumonia (CAP) curative effect and economic effect. Methods Will be our hospital from December 2009 to June 2010 50 patients were divided into two groups, patients with CAP were used respectively to cefazolin and azithromycin treatment, compared with two groups of treatment effect on drugs and economics and cost-effectiveness analysis. Results Cefazolin group of the total effective rate was 84.0%, the azithromycin the total effective rate of 92.0% between the two groups, no significant differences, P〉0.05. Two kinds of drug plan cost 1016.85 yuan respectively, 1057.45 yuan. Cost effect than 12.11, 11.49, there are significant differences, P〈0.05.Conclusion Azithromycin treatment scheme is better than the CAP cefazolin.
出处 《当代医学》 2011年第32期149-150,共2页 Contemporary Medicine
关键词 社区获得性肺炎 用药方案 疗效 经济学分析 Community-acquired pneumonia Regimen curative effect Economic analysis
  • 相关文献

参考文献6

二级参考文献19

  • 1孔晓东.药物经济学:概念、方法和应用[J].国外医学(药学分册),1994,21(1):13-18. 被引量:429
  • 2吕建平,张耀泉,区梅芳,赖清英.中、西药2种方案治疗精索静脉曲张不育症的成本-效果分析[J].中国药房,2005,16(6):436-438. 被引量:16
  • 3王鋆,张钧.药物经济学成本-效果分析[J].药学实践杂志,1995,13(4):193-197. 被引量:462
  • 4社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3057
  • 5李家泰.临床药理学[M].北京:人民卫生出版社,1998.741-742.
  • 6Bodey GP, Pan T. Mezlocillin: in vitro studies of a new broad-spectrum penicillin[J]. Antimicrob Agents Che mother,1977,11(1) :74-79.
  • 7Campoli-Richarcls DM, Brogden RN. Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties,and therapeutic use[J]. Drugs, 1987,33 (6) : 577-609.
  • 8Bush K,Jacoby GA, Medeiros AA. A functional classifi cation scheme for beta lactamases and its correlation with molecular structure[J]. Antimicrob Agents Chemother, 1995,39(6) :1211-1233.
  • 9Manncke K, Springsklee M, Heizmann WR, et al. Sulbactam in combination with mezlocillin, piperacillin or cefotaxime. Clinical and bacteriological results in the treatment of severe bacterial infections[J]. Med Klin, 1991,86 (9):454-460.
  • 10Piddock LJ,Jin YF, Turner HI.. Activity of 13 β-lactam agents combined with BRL 42715 against β-lactamase producing gram-negative bacteria compared to combina tions with clavulanic acid, tazobactam and sulbactam[J]. J Antimicrob Chemother,1993,31(1) :89-103.

共引文献168

同被引文献6

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部